USPTO serial 90844163
PRIMER DESIGN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 16, 2023
- Examiner
- STURMAN, MELISSA M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with PRIMER DESIGN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Eastleigh, GB
Camberley, Surrey, GB
Camberley, Surrey, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Rebecca Liebowitz
Rebecca Liebowitz VENABLE LLPP.O. Box 34385Washington, DC 20043-9998UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical preparations for scientific purposes, namely, for use in performing nucleic acid polymerase chain reactions for pathogen detection, water and food analysis, detection of genetically modified organisms, species identification, and bio-threat detection; chemicals preparations for use in polymerase chain reactions for research and analysis purposes, not in the medical or veterinary fields; chemicals preparations for scientific purposes, namely, for use in the extraction of DNA and RNA from cells; diagnostic preparations for scientific use, namely, primers, reagents and other chemicals preparations for use in polymerase chain reactions for laboratory purposes; chemicals reagents for use in RNA and DNA analysis other than for medical or veterinary purposes; kits comprised of reagents, vials and printed instructions for the preparation of samples for polymerase chain reaction testing for laboratory and research purposes | ACTIVE | — |
| 005 | Chemical reagents for use in polymerase chain reactions for medical and veterinary purposes; chemicals reagents for medical and veterinary use, namely, for use in performing polymerase chain reactions for pathogen detection, detection of genetically modified organisms, species identification, and veterinary and medical disease detection; diagnostic preparations, namely, chemicals preparations for use in the extraction of DNA and RNA from cells for medical and veterinary purposes; diagnostic preparations, namely, primers, reagents and other chemicals preparations for use in polymerase chain reactions for medical and veterinary purposes; chemicals reagents for use in RNA and DNA analysis for medical or veterinary purposes; kits comprised of reagents, vials and printed instructions for the preparation of samples for polymerase chain reaction testing for medical and veterinary purposes | ACTIVE | — |
| 009 | laboratory apparatus for conducting polymerase chain reactions; laboratory apparatus for conducting quantitative or real-time polymerase chain reactions; medical laboratory research instruments for DNA analysis, namely, qPCR machines; laboratory apparatus for pathogen detection, water and food analysis, detection of genetically modified organisms, species identification and bio-threat detection; laboratory apparatus for use in extracting RNA and DNA; laboratory instruments, namely, sample containers, vials, pipettes and stirrers in the nature of magnetic agitators used in the preparation of DNA and RNA samples for testing; laboratory instruments, namely, racks for holding sample pipettes and vials during testing; replacement parts and fittings for all the aforesaid goods; accessories for the aforesaid goods, namely, petri dishes, pipettes and test tubes; all the foregoing being for laboratory and research purposes | ACTIVE | — |
| 010 | diagnostic apparatus for conducting polymerase chain reactions; diagnostic apparatus for conducting quantitative or real-time polymerase chain reactions; diagnostic apparatus namely, qPCR machines; diagnostic apparatus for pathogen detection, water and food analysis, detection of genetically modified organisms, species identification and bio-threat detection; diagnostic apparatus for use in extracting RNA and DNA; medical instruments, namely, sample containers, vials, dropping pipettes and stirrers in the nature of magnetic agitators used in the preparation of DNA AND RNA samples for testing; medical instruments, namely, racks for holding samples tubes and vials during testing; replacement parts and fittings for all the aforesaid goods; accessories for the aforesaid goods, namely, dropping pipettes, medical sample tubes and vials; all the foregoing being for medical or veterinary purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Primer Design Limited
- Other trademarks owned by Primer Design Limited
- Other trademarks owned by Primer Design Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named PRIMER DESIGN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 21, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 21, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 21, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 21, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jun 21, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 16, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 16, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 28, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 28, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 8, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 25, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 25, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 25, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 25, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 25, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 25, 2022 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Nov 25, 2022 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Nov 25, 2022 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Nov 25, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 25, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 25, 2022 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| May 25, 2022 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 25, 2022 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 25, 2022 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 19, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 18, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 18, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 18, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 18, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 18, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 13, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 23, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 26, 2021 | NWAP | NEW APPLICATION ENTERED | — |